Dr Lal Pathlabs Ltd Competitors & Peer Comparison
Hospitals & Medical Services · Indian listed companies
Compare Dr Lal Pathlabs Ltd with 25 companies shown from the same industry classification, including Narayana Hrudayalaya Ltd, Metropolis Healthcare Ltd, Healthcare Global Enterprises Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,769 Cr. | 1,952 | 2,039/1,272 | 58.3 | 150 | 0.72 % | 28.0 % | 22.3 % | 10.0 |
| Narayana Hrudayalaya Ltd | 38,040 Cr. | 1,861 | 2,094/1,564 | 44.1 | 222 | 0.24 % | 15.5 % | 20.5 % | 10.0 |
| Metropolis Healthcare Ltd | 12,086 Cr. | 583 | 609/412 | 58.1 | 73.0 | 0.34 % | 17.8 % | 13.6 % | 2.00 |
| Healthcare Global Enterprises Ltd | 10,431 Cr. | 699 | 800/513 | 216 | 89.2 | 0.00 % | 8.30 % | 2.54 % | 10.0 |
| Thyrocare Technologies Ltd | 9,022 Cr. | 567 | 662/343 | 54.0 | 35.2 | 1.65 % | 36.1 % | 26.8 % | 10.0 |
| Artemis Medicare Services Ltd | 5,663 Cr. | 358 | 379/203 | 49.1 | 59.3 | 0.13 % | 14.5 % | 11.9 % | 1.00 |
| Indraprastha Medical Corporation Ltd | 3,352 Cr. | 366 | 641/342 | 17.8 | 80.8 | 1.09 % | 35.8 % | 27.4 % | 10.0 |
| Sakar Healthcare Ltd | 2,527 Cr. | 1,136 | 1,230/346 | 70.0 | 146 | 0.00 % | 12.4 % | 9.99 % | 10.0 |
| Fortis Healthcare Ltd | 63,254 Cr. | 838 | 1,105/767 | 59.3 | 131 | 0.12 % | 13.4 % | 11.2 % | 10.0 |
| Shalby Ltd | 1,589 Cr. | 147 | 273/126 | 40.4 | 93.1 | 0.00 % | 6.12 % | 2.45 % | 10.0 |
| Asarfi Hospital Ltd | 349 Cr. | 177 | 257/123 | 19.2 | 52.2 | 0.00 % | 18.8 % | 19.0 % | 10.0 |
| Lotus Eye Hospital & Institute Ltd | 239 Cr. | 115 | 153/97.6 | 1,496 | 28.9 | 0.00 % | 1.41 % | 0.13 % | 10.0 |
| Aashka Hospitals Ltd | 207 Cr. | 88.5 | 99.5/59.0 | 72.9 | 44.1 | 0.00 % | 4.05 % | 2.80 % | 10.0 |
| Aspira Pathlab & Diagnostics Ltd | 134 Cr. | 130 | 139/49.0 | 7.09 | 0.00 % | 2.84 % | 0.69 % | 10.0 | |
| Fortis Malar Hospitals Ltd | 77.4 Cr. | 41.3 | 76.0/40.0 | 596 | 18.3 | 0.00 % | 14.6 % | 12.8 % | 10.0 |
| NG Industries Ltd | 36.5 Cr. | 109 | 160/100 | 18.9 | 100 | 3.21 % | 5.88 % | 4.80 % | 10.0 |
| Deccan Health Care Ltd | 28.8 Cr. | 11.6 | 20.0/6.65 | 12.4 | 44.5 | 0.00 % | 3.09 % | 2.11 % | 10.0 |
| Chennai Meenakshi Multispeciality Hospital Ltd | 28.6 Cr. | 38.3 | 57.5/31.5 | 4.11 | 0.00 % | 3.07 % | % | 10.0 | |
| Global Longlife Hospital and Research Ltd | 14.7 Cr. | 14.0 | 26.7/9.00 | 22.6 | 0.00 % | 3.92 % | 6.81 % | 10.0 | |
| Dhanvantri Jeevan Rekha Ltd | 10.3 Cr. | 25.2 | 35.9/19.5 | 20.2 | 25.6 | 0.00 % | 3.97 % | 3.78 % | 10.0 |
| Dolphin Medical Services Ltd | 9.51 Cr. | 6.30 | 9.57/1.98 | 158 | 6.68 | 0.00 % | 0.64 % | 0.60 % | 10.0 |
| Family Care Hospitals Ltd | 9.51 Cr. | 1.76 | 4.98/1.74 | 1.75 | 0.00 % | 23.2 % | 35.4 % | 10.0 | |
| Dr Lalchandani Labs Ltd | 6.26 Cr. | 7.25 | 18.0/5.97 | 104 | 16.4 | 0.00 % | 0.79 % | 0.50 % | 10.0 |
| Gian Lifecare Ltd | 4.86 Cr. | 4.70 | 16.2/4.51 | 18.7 | 0.00 % | 3.00 % | 0.81 % | 10.0 | |
| Aster DM Healthcare Ltd | 66,195 Cr. | 759 | 891/519 | 183 | 81.1 | 0.40 % | 11.6 % | 11.3 % | 10.0 |
| Max Healthcare Institute Ltd | 98,694 Cr. | 1,014 | 1,222/903 | 65.9 | 110 | 0.20 % | 14.7 % | 14.7 % | 10.0 |
| Industry Average | 17,503.24 Cr | 738.48 | 157.93 | 85.95 | 0.31% | 11.88% | 11.00% | 9.19 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Dr Lal Pathlabs Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Dr Lal Pathlabs Ltd analysis · Explore all Hospitals & Medical Services stocks